pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·1h ago·1 min read
save

Medicaid to End Funding for Gender-Affirming Surgeries and Hormone Therapy for Transgender Youth

Aug 11, 2026·read at STAT ↗RegulatoryNegative

The Trump administration announced that Medicaid will no longer cover gender-affirming surgeries and hormone treatments for minors.

The change also applies to the Children’s Health Insurance Program, which will stop paying for these services for individuals under 19, though mental-health services will remain covered.

The policy is slated to take effect on Oct. 13. States and private insurers may still choose to provide coverage, and many states have already enacted bans on such care.

The Centers for Medicare and Medicaid Services did not comment on the expected cost impact, and the announcement follows a broader set of actions targeting transgender individuals since the administration returned to office.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Medicaid will stop paying for some gender-affirming care for transgender minors”

read at STAT ↗
662 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Moderna, Inc.Ultragenyx Pharmaceutical Inc.
topics
Vaccine2MelanomaPsychiatry & CNSRare DiseaseVaccinesmRNA Therapeutic

related stories

  • 9h agoAura, Schrödinger trim workforcesBioSpace
  • 5d agoOpinion: One year since Kennedy canceled mRNA vaccine projects, science shows how wrong he wasSTAT
  • Jul 1FDA says Zyn can market its pouches as safer than cigarettesSTAT
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • 5d agoThird time’s the charm for Replimune as melanoma drug earns FDA greenlightBioSpace